Interested in owning StemCellPatents.com? Contact info@stemcellpatents.com.
Patents (1436 Stem Cell Patents)

Progenitor cells from wharton's jelly of human umbilical cord

Patent Number: 7,547,546

Date of First Priority Issue: Tuesday February 11th, 2003
Date Issued: Tuesday June 16th, 2009
Assignee: Tissue Regeneration Therapeutics Inc. (Toronto, Ontario, CA)
Inventors: Davies; John E. (Toronto, CA), Baksh; Dolores (Mississauga, CA), Sarugaser; Rahul (Toronto, CA), Hosseini; Morris (Braunschweig, DE), Lickorish; Antony D. S. (Toronto, CA)

Comments: No comments

This patent covers methods of extracting an adherent mesenchymal-like stem cells from the Wharton's Jelly of the umbilical cord.  The extracted cells are negative for MHC and are termed by the inventors human umbilical cord perivascular (HUCPV) cells.  In the examples section the the cells are demonstrated to be capable of differentiating into osteocytes, chondrocytes, adipocytes, and myocytes.

The first independent claim covers "A method of obtaining a population of human umbilical cord perivascular (HUCPV) cells, comprising: (a) obtaining an excised blood vessel from human umbilical cord comprising the perivascular region of said vessel; and (b) treating said blood vessel by enzymatic digestion of the perivascular region and isolating a population of HUCPV cells that comprise an MHC.sup.-/- phenotype from said digested perivascular region"

So if someone where to use, for example, a non-enzymatic method of isolating the HUCPV, then one could circumvent this patent.  That is the drawback with patents of methods of extraction.  It will be interesting to see if patents will be issued on composition of matter of these cells. 

However it should be noted that cells from Wharton's Jelly of similar phenotype have previously been used for a variety of applications including treatment of lung fibrosis.

The last time we interacted with the Assignee company, Dr. Jeff Turner was CEO and the model of banking cord matrix cells was being commercialized.  It will be interesting to see where the company goes now with the new CEO.

Other patents cover placental derived cells, such as Celgene's embryonic-like stem cells, which also appear to be of mesenchymal lineage.

View this patent on the USPTO website.

Added to StemCellPatents.com on Wednesday June 17th, 2009

Social & Bookmarking:Digg 'Progenitor cells from wharton's jelly of human umbilical cord ' Add 'Progenitor cells from wharton's jelly of human umbilical cord ' to del.icio.us Add 'Progenitor cells from wharton's jelly of human umbilical cord ' to Technorati Stumble 'Progenitor cells from wharton's jelly of human umbilical cord ' Add 'Progenitor cells from wharton's jelly of human umbilical cord ' to Furl Add 'Progenitor cells from wharton's jelly of human umbilical cord ' to Reddit Add 'Progenitor cells from wharton's jelly of human umbilical cord ' to Blinklist Add 'Progenitor cells from wharton's jelly of human umbilical cord ' to Ma.gnolia Share 'Progenitor cells from wharton's jelly of human umbilical cord ' on Facebook Add 'Progenitor cells from wharton's jelly of human umbilical cord ' to Google Add 'Progenitor cells from wharton's jelly of human umbilical cord ' to Yahoo Web 

Add Comment

You must be signed-in to add your comments.

Sign-in now or Join the StemCellPatents.com Community for free.



Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2019 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.10